DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice.
about
Noncoding RNAs: key molecules in understanding and treating painStudy of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma.Gene therapy for neuropathic pain by silencing of TNF-α expression with lentiviral vectors targeting the dorsal root ganglion in mice.Lentiviral gene transfer into the dorsal root ganglion of adult rats.Dorsal root ganglion - a potential new therapeutic target for neuropathic painOverexpression of endothelial nitric oxide synthase improves endothelium-dependent vasodilation in arteries infused with helper-dependent adenovirus.Safety profile of gutless adenovirus vectors delivered into the normal brain parenchyma: implications for a glioma phase 1 clinical trialSafety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastomaDNA cleavage enzymes for treatment of persistent viral infections: recent advances and the pathway forward.Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Intrathecal injection of helper-dependent adenoviral vectors results in long-term transgene expression in neuroependymal cells and neurons.Gene Therapy for Neuropathic Pain through siRNA-IRF5 Gene Delivery with Homing Peptides to Microglia
P2860
Q26998622-95A5D49A-B3ED-496C-8249-B51F29102736Q34012284-FF3FE08D-E660-4764-8F7C-82E32C1DE6CEQ35123999-0667F14B-FCB5-4E79-9E6C-CA741A50748DQ35231284-79AA6097-2434-460B-93F8-894352D85B17Q35780942-48D3B2AC-BA24-4C51-9DD2-944349F0FF4CQ36401348-94825F76-3EAB-4989-A45D-8E881E4A4280Q36534329-ACE5E919-BCD6-4E0E-AA6D-D98097101E14Q36811505-FA998AFA-7796-437D-A339-0CCF73008466Q38184158-1669C754-17FF-47AF-9707-3072E92610D6Q38614156-EF5C8A3B-8146-4DA7-A510-78020E9A41BDQ42865227-D467C195-AB93-4629-8EB4-A9E4AB3FB7B8Q56889324-5CDCCD1E-81A6-4AAE-97F6-A9F2F1328DF9
P2860
DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
DRG-targeted helper-dependent ...... ensory neuronopathies in mice.
@en
DRG-targeted helper-dependent ...... ensory neuronopathies in mice.
@nl
type
label
DRG-targeted helper-dependent ...... ensory neuronopathies in mice.
@en
DRG-targeted helper-dependent ...... ensory neuronopathies in mice.
@nl
prefLabel
DRG-targeted helper-dependent ...... ensory neuronopathies in mice.
@en
DRG-targeted helper-dependent ...... ensory neuronopathies in mice.
@nl
P2093
P2860
P356
P1476
DRG-targeted helper-dependent ...... sensory neuronopathies in mice
@en
P2093
Andrew H Baker
Angelika B Kritz
Hideto Kojima
Kazuhiro Oka
Lawrence Chan
Tomoya Terashima
P2860
P304
P356
10.1172/JCI39038
P407
P577
2009-07-01T00:00:00Z